✦ LIBER ✦

A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas

✍ Scribed by Claes Tropé; Janne Kærn; Ignace Vergote; Svein Vossli

Publisher: Springer
Year: 1990
Tongue: English
Weight: 246 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685418

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, etoposide, and ifosfamide in

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

✍ Adriano Paccagnella; Adolfo Favaretto; Alba Brandes; Cristina Ghiotto; Driano Fo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 2 views

A Phase II study of paclitaxel-ifosfamid

A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

✍ Christos Kosmas; Nicolas B. Tsavaris; Aristidis Polyzos; Haralambos P. Kalofonos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

A phase I study of paclitaxel and altret

A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer

✍ Ian Olver; Margaret Davy; Diana Lüftner; So-Hyang Park; Merrill Egorin; Andrew E 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 96 KB

A phase ii study of the combination of e

A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

✍ Thomas E. Elliott; Charles G. Moertel; Harry S. Wieand; Richard G. Hahn; James B 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/mz/day X 3 days) plus cisplatin (45 mg/mzday on days 2 and 3). Both drugs were given by constant intravenous infusion and repeated every 4 weeks. Common toxic reactions inc

Phase II study of paclitaxel combined wi

Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens

✍ N. Baize; A. Abakar-Mahamat; N. Mounier; F. Berthier; F. X. Caroli-Bosc 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 276 KB

Phase II study of capecitabine and cispl

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma

✍ Yu-Hong Li; Feng-Hua Wang; Wen-Qi Jiang; Xiao-Juan Xiang; Yan-Ming Deng; Guo-Qin 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 256 KB